- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 24, 2025 | 382.53M sh |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $192.24M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $669.29M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $1.1B |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $41.4M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $44.14M |
| Current Assets | FY 2024 · Dec 31, 2023 | $933.31M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $1.14B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 376.96M sh |
| Capex | FY 2024 · Dec 31, 2022 | $3.45M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$88.95M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.45 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.45 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $67.67M |
| Rd Expense restated | FY 2024 · Dec 31, 2022 | $13.13M |
| Net Income | FY 2024 · Dec 31, 2022 | −$168.73M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | −$111.43M |
| Gross Profit restated | FY 2024 · Dec 31, 2022 | $15.44M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $86.75M |